Block Dissections Of Neck Endolymphatic Sac — Cost, Top Hospitals & Success Rates | MyMedicPlus

This page covers two distinct but related ENT/head and neck surgical procedures: neck block dissection (cervical lymph node dissection) for head and neck cancer, and endolymphatic sac surgery for refractory Meniere's disease.

Neck block dissection (cervical lymphadenectomy) is a major head and neck oncological procedure in which cervical lymph nodes, lymphatic channels, and potentially associated structures in the neck are surgically removed. Cervical lymph nodes are the primary regional drainage sites for cancers of the oral cavity, oropharynx, larynx, thyroid, salivary glands, skin of the head and neck, and nasal cavity. Removing involved lymph nodes eliminates regional metastases and allows pathological staging, which guides adjuvant treatment decisions (radiotherapy, chemotherapy). Neck dissections are classified as radical (removing all five levels of neck nodes plus the sternocleidomastoid muscle, internal jugular vein, and spinal accessory nerve), modified radical (sparing one or more non-lymphatic structures), selective (removing specific node levels based on primary tumour drainage patterns), and extended (including additional structures such as the carotid artery, hypoglossal nerve, or skin).

Endolymphatic sac surgery (decompression or endolymphatic sac mastoid shunt) is a hearing-preserving surgical option for refractory Meniere's disease — a chronic inner ear disorder characterised by episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. The endolymphatic sac is a membranous structure in the temporal bone responsible for resorbing endolymphatic fluid; surgical decompression or drainage of this sac aims to reduce endolymphatic hydrops (excessive endolymph fluid pressure) — the pathophysiological basis of Meniere's disease.

Neck dissection is indicated as part of the surgical treatment of head and neck squamous cell carcinomas (oral cavity, oropharynx, hypopharynx, larynx — the most common indications), well-differentiated thyroid cancers with lymph node metastases (particularly papillary thyroid carcinoma with lateral neck nodal disease), melanoma with cervical lymph node metastases, salivary gland malignancies, and unknown primary cancers presenting as cervical lymph node metastases. Selective neck dissection has largely replaced radical neck dissection for most head and neck cancers, preserving function while achieving equivalent oncological control for N0 and N1 disease.

Endolymphatic sac surgery is indicated for patients with definitively diagnosed Meniere's disease (meeting AAO-HNS criteria for definite or probable Meniere's) who have disabling vertigo attacks uncontrolled by 3–6 months of maximum medical management (low-sodium diet, diuretics, vestibular suppressants). It is specifically selected over more ablative procedures (gentamicin intratympanic injection, labyrinthectomy, vestibular nerve section) when the patient has serviceable residual hearing and wishes to preserve hearing function. Bilateral Meniere's disease or Meniere's in the only-hearing ear makes ablative surgery inappropriate, making endolymphatic sac surgery the preferred surgical option.

For neck dissection, any patient with surgically resectable head and neck cancer involving or at significant risk of involving regional lymph nodes is a candidate. CT, MRI, and PET-CT staging determines nodal status and guides the extent of neck dissection required. Sentinel lymph node biopsy is an emerging technique for clinically N0 oral cavity cancers, allowing selective dissection only in the small proportion with occult metastases. Performance status, comorbidities, and prior radiotherapy to the neck all influence the technical complexity and risks of neck dissection.

For endolymphatic sac surgery, candidates have confirmed Meniere's disease with disabling vertigo attacks (typically 6 or more per year causing significant functional limitation), failure of maximum dietary and medical management, useful residual hearing in the affected ear (pure-tone average better than 50 dB), and no prior ear surgery affecting the mastoid. Audiometric assessment, electrocochleography (ECoG), glycerol test, and MRI with gadolinium HYDO sequence to visualise endolymphatic hydrops are performed pre-operatively. Patients must understand the limited predictability of outcome and be counselled about alternative procedures.

Selective neck dissection removes only the nodal levels most at risk for a given primary site: levels I–III for oral cavity cancers, levels II–IV for larynx and hypopharynx, level VI (central neck) for thyroid cancers. Modified radical neck dissection (MRND) preserves the spinal accessory nerve (and usually the internal jugular vein and sternocleidomastoid muscle) while removing all five cervical nodal levels — indicated for N1 disease with small nodes. Radical neck dissection (RND) sacrifices the spinal accessory nerve, sternocleidomastoid, and internal jugular vein, reserved for bulky N2–N3 disease where these structures are involved.

Endolymphatic sac decompression removes the mastoid bone overlying the endolymphatic sac to relieve external pressure on the sac. Endolymphatic sac mastoid shunt places a small silastic tube or valve from the endolymphatic sac into the mastoid cavity or subarachnoid space to drain excess endolymph. Both procedures are performed through a post-auricular incision via mastoidectomy, using the operating microscope. The controversy surrounding endolymphatic sac surgery centres on the Sham Surgery Trial (1981, Thomsen et al.) which found no significant difference between sham and active surgery — subsequent studies and meta-analyses have provided more nuanced and supportive evidence, making it a contested but still practised procedure.

Selecting the most appropriate Block Dissections Of Neck Endolymphatic Sac approach requires a structured assessment of patient-specific factors. The treating specialist evaluates disease severity, prior treatment history, comorbidities, and patient preferences before recommending a specific protocol. Combination approaches are often more effective than monotherapy — integrating pharmacological, procedural, or rehabilitative elements to address multiple disease mechanisms simultaneously. Dose or intensity is titrated incrementally based on clinical response, tolerability, and objective outcome measures. In patients with refractory disease or inadequate response to first-line protocols, escalation to higher-intensity or specialist-delivered treatment options is indicated. Multidisciplinary team (MDT) review ensures that surgical, medical, and allied health perspectives are integrated into the final management plan, particularly for complex or high-risk cases where multiple treatment pathways are viable and the risk-benefit balance requires careful deliberation.

Neck dissection achieves regional disease control and accurate pathological staging, enabling optimised adjuvant treatment planning. For N0 elective dissections of oral cavity cancers, sentinel node biopsy or selective neck dissection reduces occult nodal failure rates from approximately 20–30% (observation) to under 5%. For established N1-N2 disease, neck dissection combined with primary tumour resection and post-operative radiotherapy achieves 5-year locoregional control rates of 60–85% depending on T-stage and nodal burden.

Endolymphatic sac surgery achieves vertigo control (cessation or significant reduction of disabling attacks) in approximately 60–75% of patients at 2 years, with hearing preservation in most. Tinnitus and aural fullness improvement occurs in a subset of patients. The procedure is conservative — if it fails, more definitive ablative procedures remain available. Compared with intratympanic gentamicin ablation, endolymphatic sac surgery offers the advantage of hearing preservation in patients with still-useful residual hearing.

Neck dissection carries significant morbidity depending on the extent of surgery. Spinal accessory nerve sacrifice in radical neck dissection causes ipsilateral shoulder drop, pain, and inability to raise the arm above shoulder height — a chronic disability managed with physiotherapy. Internal jugular vein sacrifice causes transient facial oedema. Chylous fistula (lymph leak from the thoracic duct on the left neck) occurs in approximately 1–3% of left neck dissections, managed with dietary modification and occasionally surgical ligation. Marginal mandibular and lingual nerve injury affects facial movement and tongue sensation. Carotid artery injury is a rare but life-threatening complication. Bilateral simultaneous neck dissection carries a risk of intracranial venous hypertension if both internal jugular veins are ligated.

Endolymphatic sac surgery carries risks of sensorineural hearing loss (1–3% risk of worsening hearing due to the proximity to the posterior fossa), perilymph fistula from inadvertent opening of the endolymphatic duct, CSF leak, facial nerve injury (rare given anatomical distance), and infection. The most significant limitation is unpredictable efficacy — a proportion of patients do not respond or relapse.

After neck dissection, drains are maintained for 1–3 days until output decreases below 30 mL/24 hours. Shoulder physiotherapy commences within 1–2 weeks, particularly for patients who had spinal accessory nerve sacrifice, to prevent permanent shoulder dysfunction. Post-operative radiotherapy or chemoradiotherapy is initiated within 6 weeks if indicated by pathological staging (extracapsular nodal extension, multiple positive nodes, positive margins). Oncology follow-up with imaging and endoscopy is scheduled every 3 months for 2 years.

After endolymphatic sac surgery, patients are admitted overnight and discharged with vestibular suppressants and analgesics. Post-operative vertigo in the first 1–2 weeks is managed conservatively. Audiometric assessment is performed at 6 weeks to confirm hearing preservation. Vertigo diary monitoring continues for 6–24 months to assess the procedure's efficacy. Patients are reviewed at 6 weeks, 6 months, and 1 year post-operatively. If vertigo is not controlled by 12 months, second-line surgical options (intratympanic gentamicin or vestibular nerve section) are discussed.

Neck dissection as part of head and neck cancer surgery is a major procedure with significant associated costs. In the United States, selective neck dissection combined with primary tumour resection costs USD 20,000–60,000 or more depending on concurrent procedures, reconstruction requirements, and length of stay. NHS covers these procedures as cancer treatments in the UK. Endolymphatic sac surgery in the US costs USD 8,000–20,000; UK private costs are GBP 4,000–10,000.

For international patients seeking head and neck cancer surgery, India's Tata Memorial Hospital (Mumbai), AIIMS, Apollo, and Manipal hospitals provide comprehensive head and neck oncological services at costs 70–85% lower than US private rates. Selective neck dissection combined with primary surgery costs USD 4,000–12,000 at major Indian cancer centres. Endolymphatic sac surgery costs USD 1,500–4,000. Thailand, Turkey, and Singapore are further destinations with specialist head and neck surgical programmes.

For head and neck cancers, primary chemoradiotherapy (organ preservation protocols) is an alternative to surgery for laryngeal, oropharyngeal, and hypopharyngeal cancers, achieving equivalent survival outcomes while preserving laryngeal function in appropriately selected patients. TORS (transoral robotic surgery) and TOLS (transoral laser surgery) are minimally invasive surgical alternatives for early oropharyngeal and laryngeal cancers, often combined with selective neck dissection.

For Meniere's disease, intratympanic corticosteroid injection is a non-ablative medical treatment associated with vertigo control in approximately 50–70% of patients and is frequently attempted before endolymphatic sac surgery. Intratympanic gentamicin injection achieves chemical ablation of vestibular hair cells, controlling vertigo in approximately 80–90% of cases but with a 25–30% risk of worsening sensorineural hearing loss — acceptable when hearing is already severely compromised but not first-line when hearing is preserved. Vestibular nerve section (posterior fossa approach) achieves 90–95% vertigo control with hearing preservation and is preferred by some surgeons over endolymphatic sac surgery for its higher efficacy.